Fujifilm just announced the X Summit OMIYA 2020 which will take place on October 15 at 9:00 AM EST. It will be streamed on youtube, which we will cover here as we have in the past so don’t forget to join us. Fujifilm will likely announce multiple products including the Fujifilm X-S10 during the event […]
Started Development of Highly Sensitive and Rapid Antigen Test Kit For New Coronavirus Applying silver halide amplification technology for photo development FUJIFILM Corporation (President: Kenji Sukeno) has started the development of a new coronavirus (SARS-CoV-2) antigen test kit. We aim to put the new coronavirus antigen test kit into practical use at an early stage by using […]
Fujifilm Wins Good Design Award With 27 Products in a Wide Range of Business Fields – Fujifilm honored with the largest number of award-winning products among the participants for the second consecutive year – Four products including binoculars and magnetic tape storage media selected for Good Design Best 100 TOKYO, October 1, 2020 — FUJIFILM […]
Fujifilm Concludes a Manufacturing Contract Agreement with VLP Therapeutics, for a COVID-19 Vaccine Formulation – Process development and manufacture of formulations using lipid nanoparticles Drug Delivery System technology – TOKYO, October 1, 2020 — FUJIFILM Corporation (President: Kenji Sukeno) announces the conclusion of a manufacturing contract agreement with biotechnology company, VLP Therapeutics Japan LLC (Representative […]
New President and Managing Director for Fujifilm in Europe Toshihisa “Toshi” Iida appointed new President and Managing Director of Fujifilm in Europe as Masato “Mark” Yamamoto departs to take up a Board Director position at FUJIFILM Holdings Corporation, Tokyo, Japan. Effective 1st September, Toshihisa “Toshi” Iida has taken up the position of President and Managing Director for […]
Anti-influenza drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 patients TOKYO, September 23, 2020 — FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada; hereinafter “FUJIFILM Toyama Chemical”) has announced today that primary endpoint has been met in phase III clinical trial of “Avigan Tablet” (generic name: favipiravir, “Avigan”) conducted […]
